Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe
The objective of the study was to evaluate and compare the diagnostic accuracy (sensitivities and specificities) of serological tests that are currently in use for diagnosis of LB in clinical laboratories in Northern Europe, by use of a large serum panel. The panel consisted of 195 serum samples from well-characterized and classified patients under investigation for clinically suspected LB (nā=ā59) including patients with Lyme neuroborreliosis, Lyme arthritis, acrodermatitis chronica atrophicans, erythema migrans or other diseases (nā=ā112). A total of 201 serum samples from healthy blood donors were also included. The panel (396 serum samples altogether) was sent to 12 clinical laboratories (using five different ELISA methods) as blinded for group affiliation and the laboratories were asked to perform serological analysis according to their routine procedure. The results from the study demonstrated high diagnostic concordance between the laboratories using the same diagnostic assay and lower diagnostic concordance between laboratories using different diagnostic assays. For IgG, the results were in general rather homo genous and showed an average sensitivity of 88% (range 85ā91%) compared to IgM which showed lower average sensitivity of 59% (range 50ā67%) and more heterogeneous results between assays and laboratories.
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
More News: Arthritis | Brain | Infectious Diseases | Laboratory Medicine | Lyme Disease | Microbiology | Neurology | Rheumatology | Study | Tickborne Diseases